Indeed, they observed that SOX2, a marker for neural stem cells implicated in the maintenance of cancer stem cells and therapeutic resistance of cancer cells, was observed only when endothelial and glioblastoma cells were grown compartmentalized and not when they are mixed. The gene discussed is SOX2; the disease is cancer.